Annual Drug Patent Expirations for EPHEDRINE+SULFATE Ephedrine Sulfate is a drug marketed by Amneal, Dr Reddys, Endo Operations, Eugia Pharma, […]
Source
New patent for Endo Operations drug EPHEDRINE SULFATE Read Post »
Annual Drug Patent Expirations for ROCKLATAN Rocklatan is a drug marketed by Alcon Labs Inc and is included in one […]
Source
Annual Drug Patent Expirations for RHOPRESSA Rhopressa is a drug marketed by Alcon Labs Inc and is included in one […]
Source
Annual Drug Patent Expirations for ZORYVE Zoryve is a drug marketed by Arcutis and is included in two NDAs. It […]
Source
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in […]
Source
Annual Drug Patent Expirations for AUGTYRO Augtyro is a drug marketed by Bristol and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two […]
Source
Annual Drug Patent Expirations for ZORYVE Zoryve is a drug marketed by Arcutis and is included in two NDAs. It […]
Source
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in […]
Source
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one […]
Source